Wang, Q., Yang, Y., Yang, M., Li, X., & Chen, K. (2020). High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations. Aging (Albany NY).
Chicago-stil citatWang, Qinghua, Yichen Yang, Meng Yang, Xiangchun Li, och Kexin Chen. "High Mutation Load, Immune-activated Microenvironment, Favorable Outcome, and Better Immunotherapeutic Efficacy in Melanoma Patients Harboring MUC16/CA125 Mutations." Aging (Albany NY) 2020.
MLA-referensWang, Qinghua, et al. "High Mutation Load, Immune-activated Microenvironment, Favorable Outcome, and Better Immunotherapeutic Efficacy in Melanoma Patients Harboring MUC16/CA125 Mutations." Aging (Albany NY) 2020.